Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
暂无分享,去创建一个
Howard Y. Chang | Ansuman T. Satpathy | Wing Hong Wong | David G Gennert | W. Greenleaf | C. Mackall | Zhana Duren | Yang Zhao | E. Sotillo | Rachel C. Lynn | Jeffrey M. Granja | Evan W. Weber | Maxwell R Mumbach
[1] C. Brander,et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells , 2020, Science Immunology.
[2] K. Verhamme,et al. Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database , 2020, Frontiers in Pharmacology.
[3] E. Wherry,et al. Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. , 2020, Immunity.
[4] W. Wong,et al. Time course regulatory analysis based on paired expression and chromatin accessibility data , 2020, Genome research.
[5] G. Vahedi,et al. Joint profiling of chromatin accessibility and CAR-T integration site analysis at population and single-cell levels , 2020, Proceedings of the National Academy of Sciences.
[6] Bin Zhang,et al. T Cell Dysfunction and Exhaustion in Cancer , 2020, Frontiers in Cell and Developmental Biology.
[7] S. Maclean,et al. A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells , 2020, Molecular therapy. Methods & clinical development.
[8] Howard Y. Chang,et al. Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells , 2020, bioRxiv.
[9] B. Bengsch,et al. Use of Mass Cytometry to Profile Human T Cell Exhaustion , 2020, Frontiers in Immunology.
[10] Howard Y. Chang,et al. c-Jun overexpression in CAR T cells induces exhaustion resistance , 2019, Nature.
[11] Hoguen Kim,et al. VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers , 2019, Science Immunology.
[12] A. Heimberger,et al. Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function , 2019, Journal of Neuro-Oncology.
[13] Gong-Hong Wei,et al. Enhancer Dysfunction in 3D Genome and Disease , 2019, Cells.
[14] Yan Zhang,et al. T Cell Dysfunction in Cancer Immunity and Immunotherapy , 2019, Front. Immunol..
[15] Yong Liu,et al. TOX is a critical regulator of tumour-specific T cell differentiation , 2019, Nature.
[16] S. Berger,et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion , 2019, Nature.
[17] Haifeng Song,et al. A safe and potent anti-CD19 CAR T cell therapy , 2019, Nature Medicine.
[18] P. Sachs,et al. SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells , 2019, Nature Communications.
[19] Aaron M. Newman,et al. A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression , 2019, Nature Communications.
[20] C. Mackall,et al. CAR T cell therapy: inroads to response and resistance , 2019, Nature Reviews Immunology.
[21] F. Urnov,et al. Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major , 2018, Molecular therapy. Methods & clinical development.
[22] Ling Xu,et al. T cell senescence and CAR-T cell exhaustion in hematological malignancies , 2018, Journal of Hematology & Oncology.
[23] Hans Anton Schlößer,et al. Cytokine release syndrome , 2018, Journal of Immunotherapy for Cancer.
[24] Hans Bitter,et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia , 2018, Nature Medicine.
[25] A. Shimabukuro-Vornhagen,et al. Understanding cytokine release syndrome , 2018, Intensive Care Medicine.
[26] D. Bigner,et al. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma , 2018, Clinical Cancer Research.
[27] Howard Y. Chang,et al. Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements , 2017, Nature Genetics.
[28] Nigel P. Dyer,et al. Integration of Kinase and Calcium Signaling at the Level of Chromatin Underlies Inducible Gene Activation in T Cells , 2017, The Journal of Immunology.
[29] William J. Greenleaf,et al. chromVAR: Inferring transcription factor-associated accessibility from single-cell epigenomic data , 2017, Nature Methods.
[30] Christina S. Leslie,et al. Chromatin states define tumor-specific T cell dysfunction and reprogramming , 2017, Nature.
[31] D. Odom,et al. Complexity and conservation of regulatory landscapes underlie evolutionary resilience of mammalian gene expression , 2017, bioRxiv.
[32] A. Hoffmann,et al. Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells , 2017, Proceedings of the National Academy of Sciences.
[33] T. Reese,et al. Making Mouse Models That Reflect Human Immune Responses. , 2017, Trends in immunology.
[34] Mithat Gönen,et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection , 2017, Nature.
[35] Todd M. Allen,et al. The epigenetic landscape of T cell exhaustion , 2016, Science.
[36] S. Berger,et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade , 2016, Science.
[37] Aviv Regev,et al. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells , 2016, Cell.
[38] Howard Y. Chang,et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture , 2016, Nature Methods.
[39] James T. Robinson,et al. Juicebox Provides a Visualization System for Hi-C Contact Maps with Unlimited Zoom. , 2016, Cell systems.
[40] Neva C. Durand,et al. Juicer Provides a One-Click System for Analyzing Loop-Resolution Hi-C Experiments. , 2016, Cell systems.
[41] M. Geyer,et al. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. , 2016, Blood.
[42] Julia V. Ponomarenko,et al. Scalable Design of Paired CRISPR Guide RNAs for Genomic Deletion , 2016, bioRxiv.
[43] R. Kaplan,et al. 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors , 2015, Nature Medicine.
[44] J. T. Erichsen,et al. Enhancer Evolution across 20 Mammalian Species , 2015, Cell.
[45] Derek W Wright,et al. Gateways to the FANTOM5 promoter level mammalian expression atlas , 2015, Genome Biology.
[46] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[47] T. Meehan,et al. An atlas of active enhancers across human cell types and tissues , 2014, Nature.
[48] D. Odom,et al. Evolution of transcription factor binding in metazoans — mechanisms and functional implications , 2014, Nature Reviews Genetics.
[49] William Stafford Noble,et al. Statistical confidence estimation for Hi-C data reveals regulatory chromatin contacts , 2014, Genome research.
[50] J. Rasko,et al. CTCF and BORIS in genome regulation and cancer. , 2014, Current opinion in genetics & development.
[51] Thomas M. Schmitt,et al. Re‐adapting T cells for cancer therapy: from mouse models to clinical trials , 2014, Immunological reviews.
[52] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[53] J. Yates,et al. MicroRNA Regulation of Molecular Networks Mapped by Global MicroRNA, mRNA, and Protein Expression in Activated T Lymphocytes , 2011, The Journal of Immunology.
[54] Michael J. Zilliox,et al. Phenotype, Function, and Gene Expression Profiles of Programmed Death-1hi CD8 T Cells in Healthy Human Adults , 2011, The Journal of Immunology.
[55] J. Kirkwood,et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients , 2010, The Journal of experimental medicine.
[56] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[57] Cory Y. McLean,et al. GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.
[58] Xue-jie Wu,et al. Hepatoma cells up-regulate expression of programmed cell death-1 on T cells. , 2008, World journal of gastroenterology.
[59] E. Wherry,et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. , 2007, Immunity.
[60] Shelly C. Lu,et al. Nrf1 and Nrf2 Regulate Rat Glutamate-Cysteine Ligase Catalytic Subunit Transcription Indirectly via NF-κB and AP-1 , 2005, Molecular and Cellular Biology.
[61] J. Lieberman,et al. A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[62] T. Toki,et al. Molecular Cloning and Functional Characterization of a New Cap’n’ Collar Family Transcription Factor Nrf3* , 1999, The Journal of Biological Chemistry.
[63] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[64] T. Baumruker,et al. Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells. , 1998, Nucleic acids research.
[65] T. Curran,et al. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. , 1994, Oncogene.
[66] Rolf M. Zinkernagel,et al. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.
[67] Peng-Kai Wu. Faculty Opinions recommendation of Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. , 2022, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.